Advertisement

Cyclic Nucleotide Levels in the Gerbil Cerebral Cortex, Cerebellum and Spinal Cord Following Bilateral Ischemia

  • W. D. Lust
  • M. Kobayashi
  • B. B. Mrsulja
  • A. Wheaton
  • J. V. Passonneau
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 78)

Abstract

It is well established that the levels of cyclic nucleotides are markedly affected by an ischemic episode. Since the first demonstration by Breckeriridge that cyclic AMP increased in the decapitated mouse brain1, a number of laboratories have described the rapid large accumulation of cyclic AMP in various ischemic regions of the brain2–3. Using the gerbil model of unilateral ischemia first described by Levine and Payan4, we have previously shown that the levels of cyclic AMP increased 10-fold in the ischemic cerebral cortex, while those of cyclic GMP decreased to 50 percent of control5. The cyclic nucleotides were also determined during the recovery period following an ischemic episode6. The cyclic AMP levels at 5 min of recirculation after either 1 or 3 hours of unilateral ischemia exhibited an additional increase to a level 20-fold greater than control. During the recovery period, cyclic GMP increased from the depressed levels during ischemia to a concentration more than 2-fold greater than control. Since it is increasingly evident that the cyclic nucleotides play a role in neuronal excitability7–8, these ischemia-induced changes in cyclic nucleotides may reflect a substantial perturbation in the electrical excitability of the brain.

Keywords

Cerebral Cortex Cyclic Nucleotide Sodium Valproate Carotid Artery Occlusion Ischemic Episode 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Breckenridge, B. McL., The measurement of cyclic adenylate in tissues, Proc. Nat. Acad. Sci., U.S.A., 52 (1964) 1580–1586.CrossRefGoogle Scholar
  2. 2.
    Schmidt, M. J., Schmidt, D. E., and Robison, G. A., Cyclic AMP in the rat brain: microwave irradiation as a means of tissue fixation. In Greengard, P, Paoletti, R., and Robison, G. A. (Editors): Advances in Cyclic Nucleotide Research, Raven Press, New York, 1972, pp 425–434.Google Scholar
  3. 3.
    Kimura, H., Thomas, E., and Murad, F., Effects of decapitation, ether and pentobarbital on guanosine 3’,5’-phosphate and adenosine 3’,5’-phosphate levels in rat tissues, Biochim. Biophys. Acta, 343 (1974) 519–528.PubMedCrossRefGoogle Scholar
  4. 4.
    Levine, S., and Payan, H., Effects of ischemia and other procedures on the brain and retina of the gerbil (Meriones unguiculatus), Expl. Neurol., 16 (1966) 255–262.CrossRefGoogle Scholar
  5. 5.
    Lust, W. D., Mrsulja, B. B., Mrsulja, B. J., Passonneau, J. V., and Klatzo, I., Putative neurotransmitters and cyclic nucleotides in prolonged ischemia of the cerebral cortex, Brain Res., 98 (1975) 394–399.PubMedCrossRefGoogle Scholar
  6. 6.
    Mrsulja, B. B., Lust, W. D., Mrsulja, B. J., Passonneau, J. V., and Klatzo, I., Post-ischemic changes in certain metabolites following prolonged ischemia in the gerbil cerebral cortex, J. Neurochem,, 26 (1976) 1099–1103.CrossRefGoogle Scholar
  7. 7.
    Stone, T. W., Taylor, D. A., and Bloom, F. E., Cyclic AMP and cyclic GMP may mediate opposite neuronal responses in the rat cerebral cortex, Science, 187 (1975) 845–847.PubMedCrossRefGoogle Scholar
  8. 8.
    Bloom, F. E., Siggins, G. R., Hoffer, B. J., Segal, M., and Oliver, A. P., Cyclic nucleotides in the central synaptic actions of catecholamines. In Drummond, G. I., Greengard, P., and Robison, G. A. (Editors): Advances in Cyclic Nucleotide Research, Raven Press, New York, 1975, vol 5, pp 603–618.Google Scholar
  9. 9.
    Nelson, S. R., Schulz, D. W., Passonneau, J. V., and Lowry, O. H., Control of glycogen levels in brain, J. Neurochem., 15 (1968) 1271–1279.PubMedCrossRefGoogle Scholar
  10. 10.
    Lowry, O. H., and Passonneau, J. V., In a Flexible System of Enzymatic Analysis, Academic Press, New York, 1972, pp 151–156.Google Scholar
  11. 11.
    Steiner, A. L., Wehmann, R. E., Parker, C. W., and Kipnis, D. M., Radioimmunoassay for the measurement of cyclic nucleotides. In Greengard, P., and Robison, G. A. (Editors): Advances in Cyclic Nucleotide Research, Raven Press, New York, 1972, vol 2, pp 51–61.Google Scholar
  12. 12.
    Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. L., Protein measurement with the folin phenol reagent, J. Biol. Chem., 193 (1951) 265–275.PubMedGoogle Scholar
  13. 13.
    Hossmann, K.-A., and Sato, K., Effect of ischemia on the function of the sensorimotor cortex in cat, Electroenceph. Clin. Neurophysiol., 30 (1971) 535–545.PubMedCrossRefGoogle Scholar
  14. 14.
    Swaab, D. F., and Boer, K., The presence of biologically labile compounds during ischemia and their relationship to the EEG in rat cerebral cortex and hypothalamus, J. Neurochem., 19 (1972) 2843–2853.PubMedCrossRefGoogle Scholar
  15. 15.
    Ferrendelli, J. A., Steiner, A. L., McDougal, D. B., and Kipnis, D. M., The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellum, Biochem. Biophys. Res. Commun., 41 (1970) 1061–1067.PubMedCrossRefGoogle Scholar
  16. 16.
    Ferrendelli, J. A., Kinscherf, D. A., and Kipnis, D. M., Effects of amphetamine, chlorpromazine and reserpine on cyclic GMP and cyclic AMP levels in mouse cerebellum, Biochem. Biophys. Res. Commun., 46 (1972) 2114–2120.PubMedCrossRefGoogle Scholar
  17. 17.
    Lust, W. D., and Passonneau, J. V., Influence of certain drugs on cyclic nucleotide levels in mouse brain following electroconvulsive shock, Trans. Am. Soc. Neurochem., 4 (Abstr.) (1973) 115.Google Scholar
  18. 18.
    Mao, C. C., Guidotti, A., and Costa, E., Evidence for an involvement of GABA in the mediation of the cerebellar cyclic GMP decrease and the anticonvulsant action of diazepam, Naunyn-Schmiedeberg’s Arch. Pharmacol., 289 (1975) 369–378.CrossRefGoogle Scholar
  19. 19.
    Lust, W. D., Kupferberg, H. J., Passonneau, J. V., and Penry, J. K., On the mechanism of action of sodium valproate: the relationship of GABA and cyclic GMP levels to anticonvulsant activity. In Legg, N. J. (Editor): Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy. Tunbridge Wells, England: MCS Consultants, 1976, pp 123–129.Google Scholar
  20. 20.
    Lust, W. D., Goldberg, N. D., and Passonneau, J. V., Cyclic nucleotides in murine brain: the temporal relationship of changes induced in adenosine 3’,5’-monophosphate and guanosine 3’,5’-monophosphate following maximal electroshock or decapitation. J. Neurochem., 26 (1976) 5–10.PubMedCrossRefGoogle Scholar
  21. 21.
    Opmeer, F. A., Gumulka, S. W., Dinnendahl, V., and Schonhofer, P. S., Effects of stimulatory and depressant drugs on cyclic guanosine 3’,5’-monophosphate and adenosine 3’,5’-monophosphate levels in mouse brain, Naunyn-Schmiedeberg’s Arch. Pharmacol., 292 (1976) 259–265.CrossRefGoogle Scholar
  22. 22.
    Sattin, A., Increase in the content of adenosine 3’,5’-monophosphate in mouse forebrain during seizures and prevention of the increase by methylxanthines, J. Neurochem., 18 (1971) 1087–1096.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1977

Authors and Affiliations

  • W. D. Lust
    • 1
  • M. Kobayashi
    • 1
  • B. B. Mrsulja
    • 1
  • A. Wheaton
    • 1
  • J. V. Passonneau
    • 1
  1. 1.Laboratory of Neurochemistry and Laboratory of Neuropathology and Neuroanatomical SciencesNINCDS, NIHBethesdaUSA

Personalised recommendations